AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ArcticZymes Technologies Director's Dealing 2019

Feb 18, 2019

Director's Dealing

Opens in your device viewer

Biotec Pharmacon - Mandatory notification of trade

(Tromsø 18. February 2019) Rolf E. Engstad, CSO of Biotec BetaGlucans

has purchased 30.400 shares in Biotec Pharmacon at NOK 4.17 per share. After

this transaction holds Engstad 581.174 shares and 40.000 options in Biotec

Pharmacon

For further information, please contact

Børge Sørvoll

CFO

+47 952 90 187